CN104524524B - 一种治疗骨质疏松的药物及制备方法 - Google Patents
一种治疗骨质疏松的药物及制备方法 Download PDFInfo
- Publication number
- CN104524524B CN104524524B CN201510000459.6A CN201510000459A CN104524524B CN 104524524 B CN104524524 B CN 104524524B CN 201510000459 A CN201510000459 A CN 201510000459A CN 104524524 B CN104524524 B CN 104524524B
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- medicine
- calcined
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 91
- 229940079593 drug Drugs 0.000 title claims description 25
- 208000001132 Osteoporosis Diseases 0.000 title abstract description 53
- 238000000034 method Methods 0.000 title abstract description 8
- 210000000582 semen Anatomy 0.000 claims abstract description 58
- 241001223950 Bryoria asiatica Species 0.000 claims abstract description 21
- 241000209020 Cornus Species 0.000 claims abstract description 21
- 241000287828 Gallus gallus Species 0.000 claims abstract description 21
- 241000220350 Ulomoides dermestoides Species 0.000 claims abstract description 19
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims description 45
- 239000000843 powder Substances 0.000 claims description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 27
- 241001550206 Colla Species 0.000 claims description 26
- 238000002360 preparation method Methods 0.000 claims description 22
- 102000002322 Egg Proteins Human genes 0.000 claims description 20
- 108010000912 Egg Proteins Proteins 0.000 claims description 20
- 210000004681 ovum Anatomy 0.000 claims description 20
- 239000008187 granular material Substances 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 18
- 239000000341 volatile oil Substances 0.000 claims description 18
- 241000237636 Pheretima Species 0.000 claims description 17
- 239000010271 massa medicata fermentata Substances 0.000 claims description 17
- 239000006187 pill Substances 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 12
- 235000012907 honey Nutrition 0.000 claims description 12
- 238000007670 refining Methods 0.000 claims description 11
- 239000002552 dosage form Substances 0.000 claims description 10
- 230000001009 osteoporotic effect Effects 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 238000005325 percolation Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000012567 medical material Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 206010013786 Dry skin Diseases 0.000 claims description 3
- 239000001116 FEMA 4028 Substances 0.000 claims description 3
- 239000001828 Gelatine Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 239000006286 aqueous extract Substances 0.000 claims description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 3
- 229960004853 betadex Drugs 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000013521 mastic Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 239000002893 slag Substances 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 229960004793 sucrose Drugs 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 210000003734 kidney Anatomy 0.000 abstract description 60
- 210000000988 bone and bone Anatomy 0.000 abstract description 40
- 210000004185 liver Anatomy 0.000 abstract description 38
- 230000007812 deficiency Effects 0.000 abstract description 24
- 238000005728 strengthening Methods 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 15
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 238000005516 engineering process Methods 0.000 abstract description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 6
- 239000011575 calcium Substances 0.000 abstract description 6
- 229910052791 calcium Inorganic materials 0.000 abstract description 6
- 230000004438 eyesight Effects 0.000 abstract description 6
- 230000029087 digestion Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 235000002710 Ilex cornuta Nutrition 0.000 abstract description 3
- 241001310146 Ilex cornuta Species 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 210000002435 tendon Anatomy 0.000 abstract description 3
- 241000255789 Bombyx mori Species 0.000 abstract description 2
- 239000003292 glue Substances 0.000 abstract 2
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 241000123866 Homalomena occulta Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 235000011034 Rubus glaucus Nutrition 0.000 abstract 1
- 244000235659 Rubus idaeus Species 0.000 abstract 1
- 235000009122 Rubus idaeus Nutrition 0.000 abstract 1
- 240000003801 Sigesbeckia orientalis Species 0.000 abstract 1
- 235000003407 Sigesbeckia orientalis Nutrition 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 244000078534 Vaccinium myrtillus Species 0.000 abstract 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 235000012343 cottonseed oil Nutrition 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 34
- 210000000952 spleen Anatomy 0.000 description 34
- 210000004369 blood Anatomy 0.000 description 31
- 208000002193 Pain Diseases 0.000 description 24
- 210000002784 stomach Anatomy 0.000 description 23
- 210000003205 muscle Anatomy 0.000 description 22
- 208000008035 Back Pain Diseases 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 17
- 201000010099 disease Diseases 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 206010011224 Cough Diseases 0.000 description 16
- 210000001624 hip Anatomy 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 13
- 210000002216 heart Anatomy 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 201000001881 impotence Diseases 0.000 description 12
- 230000027939 micturition Effects 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 206010037660 Pyrexia Diseases 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 238000010792 warming Methods 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 206010039984 Senile osteoporosis Diseases 0.000 description 8
- 210000000629 knee joint Anatomy 0.000 description 8
- 230000003014 reinforcing effect Effects 0.000 description 8
- 208000010228 Erectile Dysfunction Diseases 0.000 description 7
- 208000008454 Hyperhidrosis Diseases 0.000 description 7
- 206010027514 Metrorrhagia Diseases 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 230000037182 bone density Effects 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 206010011878 Deafness Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 208000000059 Dyspnea Diseases 0.000 description 6
- 206010013975 Dyspnoeas Diseases 0.000 description 6
- 208000008930 Low Back Pain Diseases 0.000 description 6
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000035900 sweating Effects 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- 208000010392 Bone Fractures Diseases 0.000 description 5
- 206010017076 Fracture Diseases 0.000 description 5
- 208000031361 Hiccup Diseases 0.000 description 5
- 206010021118 Hypotonia Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 208000009205 Tinnitus Diseases 0.000 description 5
- 206010047513 Vision blurred Diseases 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 229940011871 estrogen Drugs 0.000 description 5
- 239000000262 estrogen Substances 0.000 description 5
- 208000017561 flaccidity Diseases 0.000 description 5
- 230000005714 functional activity Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 208000023513 hiccough Diseases 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 210000003127 knee Anatomy 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 231100000886 tinnitus Toxicity 0.000 description 5
- 208000006386 Bone Resorption Diseases 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 208000000616 Hemoptysis Diseases 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000024279 bone resorption Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000036565 night sweats Effects 0.000 description 4
- 206010029410 night sweats Diseases 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 208000001685 postmenopausal osteoporosis Diseases 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 102000055006 Calcitonin Human genes 0.000 description 3
- 108060001064 Calcitonin Proteins 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000004097 bone metabolism Effects 0.000 description 3
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 3
- 229960004015 calcitonin Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 230000011164 ossification Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000242 Abortion threatened Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010065687 Bone loss Diseases 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000036119 Frailty Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000008899 Habitual abortion Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000009889 Herpes Simplex Diseases 0.000 description 2
- 206010020850 Hyperthyroidism Diseases 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 241001529246 Platymiscium Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 241000522620 Scorpio Species 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000005985 Threatened Abortion Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 2
- 229960002535 alfacalcidol Drugs 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000004227 calcium gluconate Substances 0.000 description 2
- 229960004494 calcium gluconate Drugs 0.000 description 2
- 235000013927 calcium gluconate Nutrition 0.000 description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 229940121657 clinical drug Drugs 0.000 description 2
- ACSIXWWBWUQEHA-UHFFFAOYSA-N clodronic acid Chemical compound OP(O)(=O)C(Cl)(Cl)P(O)(O)=O ACSIXWWBWUQEHA-UHFFFAOYSA-N 0.000 description 2
- 229960002286 clodronic acid Drugs 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 208000026500 emaciation Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 206010036596 premature ejaculation Diseases 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000009490 scorpio Substances 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- -1 sublimed preparation Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- CHZJRGNDJLJLAW-RIQJQHKOSA-N (8r,9s,13s,14s,16r,17r)-3-cyclopentyloxy-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-16,17-diol Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1C[C@@H](O)[C@@]4(O)C#C)C)CC2=CC=3OC1CCCC1 CHZJRGNDJLJLAW-RIQJQHKOSA-N 0.000 description 1
- GMRQFYUYWCNGIN-ZVUFCXRFSA-N 1,25-dihydroxy vitamin D3 Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-ZVUFCXRFSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000007743 Acute Abdomen Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 241000255783 Bombycidae Species 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010010214 Compression fracture Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000208421 Ericaceae Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 241001489138 Haliotis diversicolor Species 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020674 Hypermetabolism Diseases 0.000 description 1
- 201000002980 Hyperparathyroidism Diseases 0.000 description 1
- 241000209035 Ilex Species 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010049949 Intercostal neuralgia Diseases 0.000 description 1
- SFBODOKJTYAUCM-UHFFFAOYSA-N Ipriflavone Chemical compound C=1C(OC(C)C)=CC=C(C2=O)C=1OC=C2C1=CC=CC=C1 SFBODOKJTYAUCM-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 235000019084 Selinum monnieri Nutrition 0.000 description 1
- 244000296102 Selinum monnieri Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- 241000254107 Tenebrionidae Species 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TUMPRCUDDNLXTI-UHFFFAOYSA-K [Na+].O(P([O-])(=O)OP(=O)([O-])[O-])OCC.[Na+].[Na+] Chemical compound [Na+].O(P([O-])(=O)OP(=O)([O-])[O-])OCC.[Na+].[Na+] TUMPRCUDDNLXTI-UHFFFAOYSA-K 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000008416 bone turnover Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 235000020964 calcitriol Nutrition 0.000 description 1
- 239000011612 calcitriol Substances 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- DDPFHDCZUJFNAT-PZPWKVFESA-N chembl2104402 Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 DDPFHDCZUJFNAT-PZPWKVFESA-N 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-L diphosphonate(2-) Chemical compound [O-]P(=O)OP([O-])=O XQRLCLUYWUNEEH-UHFFFAOYSA-L 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 108700032313 elcatonin Proteins 0.000 description 1
- 229960000756 elcatonin Drugs 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000002316 fumigant Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 201000000916 idiopathic juvenile osteoporosis Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229960005431 ipriflavone Drugs 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229950007863 nilestriol Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000001749 optic atrophy Diseases 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000008807 pathological lesion Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 201000010384 renal tubular acidosis Diseases 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229940106904 rocaltrol Drugs 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- WZDGZWOAQTVYBX-XOINTXKNSA-N tibolone Chemical compound C([C@@H]12)C[C@]3(C)[C@@](C#C)(O)CC[C@H]3[C@@H]1[C@H](C)CC1=C2CCC(=O)C1 WZDGZWOAQTVYBX-XOINTXKNSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/09—Lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种治疗骨质疏松的药物及制备方法,其中,药物包括以下原料药材:熟地、龟板胶、鸡子黄、鳆鱼、白芍、鹿角胶、棉花子、头发七、蛇床子、南烛子、燕窝、枸杞、豨莶、覆盆子、原蚕蛾、枸骨根、骨碎补、菟丝子、千年健、洋虫、山茱萸、山药、陈皮、干姜、鳖甲、地龙、秦艽、桑枝、煅龙骨、煅牡蛎、煅石膏、葛根、神曲和莱菔子。本发明的有益效果是:本发明的药物用于治疗骨质疏松,具有滋补肝肾、强筋壮骨的功效,兼以益精明目、填精生髓、清退虚热、活血通络、涩精补钙、消食化积,配方简单、制作工艺简便,毒副作用小且给药方便,药剂易于制造,成本低廉。
Description
技术领域
本发明涉及药学技术领域,尤其涉及一种治疗骨质疏松的药物及制备方法。
背景技术
骨质疏松是多重原因引起的一组骨病,骨组织有正常的钙化,钙盐与基质呈正常比例,以单位体积内骨组织量减少为特点的代谢性骨病变。在多数骨质疏松中,骨组织的减少主要由于骨质吸收增多所致。发病多缓慢个别较快,以骨骼疼痛、易于骨折为特征生化检查基本正常。病理解剖可见骨皮质菲薄,骨小梁稀疏萎缩类骨质层不厚。
目前, 全世界约有2亿人患骨质疏松症, 其发病率已跃居世界各种常见病的第7位。也有报道显示居常见疾病的第6位。骨质疏松症已被公认为严重的社会公共健康问题。
症状
(1) 疼痛
原发性骨质疏松症最常见的症状,以腰背痛多见,占疼痛患者中的70%-80%。疼痛沿脊柱向两侧扩散,仰卧或坐位时疼痛减轻,直立时后伸或久立、久坐时疼痛加剧,日间疼痛轻,夜间和清晨醒来时加重,弯腰、肌肉运动、咳嗽、大便用力时加重。 一般骨量丢失12%以上时即可出现骨痛。老年骨质疏松症时,椎体骨小梁萎缩,数量减少,椎体压缩变形,脊柱前屈,腰疹肌为了纠正脊柱前屈,加倍收缩,肌肉疲劳甚至痉挛,产生疼痛。新近胸腰椎压缩性骨折,亦可产生急性疼痛,相应部位的脊柱棘突可有强烈压痛及叩击痛,一般2-3周后可逐渐减轻,部分患者可呈慢性腰痛。若压迫相应的脊神经可产生四肢放射痛、双下肢感觉运动障碍、肋间神经痛、胸骨后疼痛类似心绞痛,也可出现上腹痛类似急腹症。若压迫脊髓、马尾还影响膀胱、直肠功能。
(2)身长缩短、驼背
多在疼痛后出现。脊椎椎体前部几乎多为松质骨组成,而且此部位是身体的支柱,负重量大,容易压缩变形,使脊椎前倾,背曲加剧,形成驼背,随着年龄增长,骨质疏松加重,驼背曲度加大,致使膝关节挛拘显著。每人有24节椎体,正常人每一椎体高度约2cm左右,老年人骨质疏松时椎体压缩,每椎体缩短2mm左右,身长平均缩短3-6cm。
(3)骨折
这是退行性骨质疏松症最常见和最严重的并发症。
(4)呼吸功能下降
胸、腰椎压缩性骨折,脊椎后弯,胸廓畸形,可使肺活量和最大换气量显著减少,患者往往可出现胸闷、气短、呼吸困难等症状。
骨质疏松系骨代谢障碍的一种全身性骨骼疾病,依据病理特点可分为高转换型骨质疏松、低转换型骨质疏松。高转换型骨质疏松是骨吸收和骨形成均增加的骨转换率增高的一种病理状态, 主要见于妇女绝经后早期、甲状旁腺功能亢进、甲状腺功能亢进和风湿性关节炎性骨病、牙周病等。低转换型骨质疏松是骨吸收增加或减少, 而骨形成率降低, 因而表现为低转换率的一种病理状态, 主要见于老年性骨质疏松。也可从病因学上简单地分为原发性、继发性骨质疏松症。原发性骨质疏松症: 除年老和绝经外无其他原因, 可分为退行性骨质疏松症和特发性骨质疏松症。退行性骨质疏松症又可分为绝经后骨质疏松症和老年性骨质疏松症。继发性骨质疏松: 是指由某些疾病或药物病理性损害骨代谢所诱发的骨质疏松属于继发性骨质疏松, 如代谢性疾病、内分泌疾病、结缔组织疾病和影响骨代谢的药物等引起的骨质疏松, 可由一种致病因素或多种致病因素引起。
骨质疏松症主要分为原发性OP和继发性OP,原发性OP 除特发性外,分为I型和II型,I型又称为绝经后骨质疏松,为高转换型,主要原因为雌性激素缺乏;II 型又称为老年性骨质疏松,为低转换型,由于年龄的老化。
1. 原发性
绝经后骨质疏松症(I型):指主要由绝经后雌激素水平低落引起的骨质疏松症,常于绝经后5-l0年发病,属原发性骨质疏松症。其特征是全身的骨量减少及骨组织微结构改变,以至骨脆性增高,易于骨折,使妇女的残废率和死亡率增加,其治疗机理主要在于调节下丘脑-垂体-卵巢轴的功能,提高绝经后妇女体内性激素水平,抑制骨吸收,并通过对机体的全身性、多环节的调节作用而达到治疗的目的。
老年性骨质疏松症(II 型):老年人肾脏虚衰,三焦气化不利;或脾胃虚弱,气血亏虚,气虚无力行血;或脾虚湿盛;或久病入络,气血运行不畅;或寒凝筋脉等均可导致瘀血痰浊痹阻筋脉,致筋骨失养;同时,痰瘀还可导致肾虚的产生及进一步衰竭,从而诱发或加重老年性骨质疏松的产生。对于老年性骨质疏松的治疗,主要以补肾(温补肾阳,填补肾精)为主,并在补肾的基础上根据其临床表现分别采取健脾益气、补益肝肾、活血化瘀、化痰通络、温化寒湿等法。
2. 继发性
继发性OP是继发于长期用药的不良反应(如糖皮质激素),或继发于甲状腺机能亢进、糖尿病、肾小管性酸中毒、多发性骨髓瘤等疾病。
世界卫生组织推荐的诊断标准:骨密度低于同性别、同种族正常人骨峰值不足一个标准差属正常(T值﹥-1),骨密度值在-1~-2.5之间为骨量减少(-2.5<T值<-1),骨密度低于或等于-2.5为骨质疏松(T值≤2.5)。骨密度降低程度符合骨质疏松诊断标准同时伴有一处或多次骨折时为严重骨质疏松。建议老年人群定期做骨密度检查。常规X射线照片可显示管状骨皮质变薄,髓腔变宽,骨小梁数目减少,其间隙也增宽。
西医疗法:原发性I型骨质疏松症属高代谢型,是由于绝经后雌激素减少,使骨吸收亢进引起骨量丢失。原发性Ⅱ型骨质疏松症,其病因是由于增龄老化所致调节激素失衡使骨形成低下。
1.雌激素:是防治绝经后骨质疏松症的首选药物。⑴雌二醇1-2mg/d。⑵乙烯雌酚0.25mg/每晚。⑶复方雌激素0.625mg/d。⑷尼尔雌醇2mg/半月。⑸利维爱。
2.降钙素:⑴降钙素。⑵益钙宁。⑶密钙息。
3.Vir D:⑴罗钙全。⑵阿法骨化醇。
4.钙制剂:⑴无机钙:1)氯化钙。2)碳酸钙。⑵有机钙:1)葡萄糖酸钙。2)乳酸钙。3)门冬氨酸钙。⑶活性钙。⑷钙尔奇D。
5.双磷酸盐:⑴氯甲双磷酸二钠。⑵羟乙基二磷酸钠。
6.异丙氧黄酮。
西药治疗:吸收情况不确定,影响食欲,容易反复。
中药治疗骨质疏松较之西药的最大的优点在于,从病理上进行根治。本发明的中药治疗原则为滋补肝肾,强筋壮骨,疗效显著;疗程较短,可降低复发率;成本价格低,给药途径方便,病人易于接受,具有临床市场推广的价值潜力。
发明内容
本发明所要解决的技术问题在于,提供了一种具有滋补肝肾,强筋壮骨的功效,主治骨质疏松的药物,配方简单、制作工艺简便,毒副作用小且给药方便,药剂易于制造,成本低廉。本发明为中药制剂,但精选气味平和的中药,使药物制剂的气味并不浓烈。本发明采用不同药性的中药材,进行了科学配伍,能达到理想的治疗效果,且安全,毒副作用小,制备简单,能直达病灶,治愈时间短,治愈后不易复发。
为解决上述技术问题,本发明提供一种治疗骨质疏松的药物,包括以下原料药材:熟地、龟板胶、鸡子黄、鳆鱼、白芍、鹿角胶、棉花子、头发七、蛇床子、南烛子、燕窝、枸杞、豨莶、覆盆子、原蚕蛾、枸骨根、骨碎补、菟丝子、千年健、洋虫、山茱萸、山药、陈皮、干姜、地龙、秦艽、桑枝、煅龙骨、煅牡蛎、煅石膏、葛根、神曲和莱菔子。
所述药物中各原料药材的重量份数比为:熟地20-30份、龟板胶17-25份、鸡子黄10-18份、鳆鱼7-17份、白芍25-34份、鹿角胶28-36份、棉花子5-10份、头发七9-14份、蛇床子6-11份、南烛子6-15份、燕窝26-35份、枸杞23-38份、豨莶9-15份、覆盆子23-30份、原蚕蛾14-19份、枸骨根5-10份、骨碎补20-30份、菟丝子12-20份、千年健15-24份、洋虫10-18份、山茱萸25-36份、山药11-17份、陈皮23-34份、干姜7-15份、地龙10-17份、秦艽5-14份、桑枝6-12份、煅龙骨7-13份、煅牡蛎6-12份、煅石膏5-11份、葛根9-16份、神曲11-19份和莱菔子10-17份。
所述药物中各原料药材的重量份数比为:熟地22-28份、龟板胶18-24份、鸡子黄11-17份、鳆鱼8-14份、白芍26-32份、鹿角胶30-35份、棉花子5-9份、头发七10-13份、蛇床子7-10份、南烛子7-13份、燕窝28-33份、枸杞25-33份、豨莶10-14份、覆盆子24-29份、原蚕蛾15-18份、枸骨根6-9份、骨碎补22-28份、菟丝子13-19份、千年健17-22份、洋虫12-16份、山茱萸26-34份、山药12-15份、陈皮25-32份、干姜8-14份、地龙11-16份、秦艽7-12份、桑枝7-11份、煅龙骨8-12份、煅牡蛎7-11份、煅石膏6-10份、葛根10-15份、神曲12-18份和莱菔子11-15份。
所述药物中各原料药材的重量份数比为:熟地26份、龟板胶22份、鸡子黄11份、鳆鱼12份、白芍32份、鹿角胶33份、棉花子5份、头发七12份、蛇床子7份、南烛子13份、燕窝31份、枸杞25份、豨莶10份、覆盆子29份、原蚕蛾17份、枸骨根8份、骨碎补26份、菟丝子13份、千年健22份、洋虫14份、山茱萸30份、山药15份、陈皮29份、干姜14份、地龙16份、秦艽11份、桑枝7份、煅龙骨10份、煅牡蛎7份、煅石膏10份、葛根10份、神曲18份和莱菔子12份。
所述药物中各原料药的重量份数比为:熟地22份、龟板胶24份、鸡子黄17份、鳆鱼8份、白芍30份、鹿角胶30份、棉花子8份、头发七10份、蛇床子10份、南烛子11份、燕窝28份、枸杞33份、豨莶12份、覆盆子24份、原蚕蛾18份、枸骨根9份、骨碎补28份、菟丝子16份、千年健20份、洋虫12份、山茱萸34份、山药12份、陈皮32份、干姜12份、地龙11份、秦艽7份、桑枝11份、煅龙骨12份、煅牡蛎11份、煅石膏7份、葛根12份、神曲16份和莱菔子11份。
所述药物中各原料药材的重量份数比为:熟地28份、龟板胶18份、鸡子黄14份、鳆鱼14份、白芍26份、鹿角胶35份、棉花子9份、头发七13份、蛇床子9份、南烛子7份、燕窝33份、枸杞27份、豨莶14份、覆盆子26份、原蚕蛾15份、枸骨根6份、骨碎补22份、菟丝子19份、千年健17份、洋虫16份、山茱萸26份、山药14份、陈皮25份、干姜8份、地龙13份、秦艽12份、桑枝9份、煅龙骨8份、煅牡蛎9份、煅石膏6份、葛根15份、神曲12份和莱菔子15份。
为了更好地实现发明目的,本发明还提供一种药物的制备方法,当所述药物剂型为蜜炼丸剂时,其制备方法包括以下步骤:
步骤1:先将煅龙骨、煅牡蛎、煅石膏按所述比例混合粉碎过200目-300目筛得粉末;
步骤2:再取剩余原料药材按所述比例混合,加相对于混合物2-6倍量的83-94%乙醇浸泡1-2小时、加热提取2次,每次1-1.5小时,合并提取液、124-150目滤过,再经截流分子量为4400-98000的超滤柱超滤,超滤液减压浓缩至87℃时相对密度为1.04的浸膏,成为组分1;
步骤3:将步骤2中药渣加4-6倍量水浸泡1-2.5小时,加热煎煮1.5-2小时,过滤,浓缩滤液为浸膏状,为组分2;
步骤4:将上述组分1和组分2两种浸膏浓缩成糊状,加上步骤1得到的粉末,加蜂蜜搓成丸剂。
为了更好地实现发明目的,本发明还提供一种药物的制备方法,当所述药物的剂型为颗粒剂时,其制备方法包括以下步骤:
步骤一:先将煅龙骨、煅牡蛎、煅石膏按所述比例混合粉碎过200目-300目筛得粉末;
步骤二、将剩余所述原料药材按所述比例混合,加相对于混合物4~8倍的醇浓度为85%~95%的乙醇,加热至沸腾回流3~5小时,过滤,采用渗漉法以每分钟1~2ml的速度缓缓渗漉,收集渗漉液,随后在真空度0.06~0.09Mpa下减压浓缩至50~60℃时相对密度为1.04~1.10的膏体,喷雾干燥,喷雾干燥机的进风温度160~175℃、出风温度80~85℃,随后粉碎成粉末,制成干膏粉;
步骤三:将步骤一获得的粉末和步骤二获得的干膏粉混合均匀,然后加入相对于混合物质量0.2~0.4倍的蔗糖粉和0.1~0.2倍的糊精,制成颗粒,于40~50℃干燥,获得颗粒剂。
为了更好地实现发明目的,本发明还提供一种药物的制备方法,当所述药物的剂型为胶囊剂时,其制备方法包括以下步骤:
第一步,先将煅龙骨、煅牡蛎、煅石膏按所述比例混合,粉碎过200目-300目筛得粉末;
第二步,将熟地、龟板胶、鸡子黄、鳆鱼和白芍按所述比例混合,加相对于混合物4~6倍的水提取挥发油,将获得的挥发油用β-环糊精包合,挥发油与β-环糊精的质量比例为1∶3~6,搅拌60分钟~90分钟,温度30℃~50℃,得挥发油包合物,备用;另将水提取液浓缩至60℃时相对密度为1.15~1.17的清膏;
第三步,将鹿角胶、棉花子、头发七、蛇床子和南烛子按所述比例混合,加相对于混合物5~8倍量醇浓度为75%~90%的乙醇回流提取3~5次,每次2~3小时,分别过滤,各次滤液合并,回收乙醇,浓缩至60℃时相对密度为1.20~1.22的清膏,备用;
第四步,将剩余所述原料药材按所述比例混合,加相对于混合物8~10倍量水,煮沸6~8小时,过滤,浓缩至60℃时相对密度为1.28~1.30的清膏;
第五步,将第二步、第三步、第四步的清膏混合,60℃~70℃减压真空干燥,得干膏粉;
第六步,将第一步所得粉末、第二步所述挥发油包合物和第五步所述干膏粉充分混合得混合物,随后加入相对于100重量份所述的混合物,5~7重量份羧甲基淀粉钠、5~50重量份淀粉混合均匀,加入150~200重量份醇浓度为80%~90%乙醇制粒,干燥,整粒,随后加入相对于100重量份所述挥发油包合物和干膏粉的混合物,3~5重量份硬脂酸镁,然后装入明胶胶囊中。
为解决上述技术问题,本发明还提供一种治疗骨质疏松药物的剂型,内服药物剂型优选为:片剂、糖衣片剂、薄膜衣片剂、肠溶衣片剂、胶囊剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、冲剂、蜜丸剂、散剂、丹剂、溶液剂、注射剂、糖浆剂;外用药物剂型优选为:熏蒸剂、乳膏剂、擦剂、酊剂、软膏剂、贴片剂、栓剂、硬膏剂、凝胶剂和喷雾剂。
本发明实施例提供的技术方案带来的有益效果是:利用我国传统的中医理论,以滋补肝肾,强筋壮骨为主,兼以益精明目、填精生髓、清退虚热、活血通络、涩精补钙、消食化积,提供了一种治疗骨质疏松的药物,能够提高人的免疫力,在治疗骨质疏松方面具有廉价、无药残、纯天然性、无毒害、安全方便、功能全面等优势特点。
具体实施方式
本发明提供了一种治疗骨质疏松的药物,其中,包括以下原料药材:熟地、龟板胶、鸡子黄、鳆鱼、白芍、鹿角胶、棉花子、头发七、蛇床子、南烛子、燕窝、枸杞、豨莶、覆盆子、原蚕蛾、枸骨根、骨碎补、菟丝子、千年健、洋虫、山茱萸、山药、陈皮、干姜、地龙、秦艽、桑枝、煅龙骨、煅牡蛎、煅石膏、葛根、神曲和莱菔子。以滋补肝肾,强筋壮骨为原则,其中熟地、龟板胶、鸡子黄、鳆鱼、白芍滋阴养虚,补肝肾之阴;鹿角胶、棉花子、头发七、蛇床子温阳益精,养筋润燥; 南烛子、燕窝添精生髓,枸杞益精明目; 豨莶、覆盆子、原蚕蛾、枸骨根、骨碎补、菟丝子补肝益肾; 千年健、洋虫、山茱萸强腰膝,健筋骨;山药、陈皮、干姜温中健脾;鳖甲、地龙清退虚热;秦艽、桑枝活血通络;煅龙骨、煅牡蛎、煅石膏涩精补钙;葛根可解项背强痛;神曲、莱菔子消食化积,防止诸药滋腻碍胃。
其中,上述原料药材的药理如下:
熟地:味甘,性微温,入肝、肾经,补肾填精,养血和阴,养阴生髓,补五脏内伤不足,通血脉,利耳目,黑须发,男子五劳七伤,女子伤中胞漏,经候不调,胎产百病。《本草纲目》:“填骨髓,长肌肉,生精血。补五脏内伤不足,通血脉,利耳目,黑须发,男子五劳七伤,女子伤中胞漏,经候不调,胎产百病。”具有补血滋阴,益精填髓的作用,用于血虚萎黄;眩晕,心悸,失眠,月经不调,崩不止;肝肾阴亏,盗汗,足膝疼痛,腰膝酸软,耳鸣耳聋,头目昏花,遗精阳痿,不育不孕,月经不调,崩漏下血,须发早白,消渴,肾虚喘促等证。
龟板胶:咸、甘,微寒;归肝、肾、心经。滋阴潜阳,益肾强骨,养血补心。《本草纲目》:“补心、补肾、补血,皆以养阴也……观龟甲所主诸病,皆属阴虚血弱。”滋阴潜阳,益肾强骨,养血补心。用于阴虚潮热,骨蒸盗汗,头晕目眩,虚风内动,筋骨痿软,心虚健忘。
鸡子黄:味甘,性平。归心、肾、脾经。功效主治:阴润燥;养血熄风。主治心烦不得眠;热病痉厥;虚劳吐血;呕逆;下痢;烫伤;热疮;肝炎;小儿消化不良。①《千金·食治》:“微寒。”②《本草再新》:“味甘,性平,无毒。入心、肺、肾三经。”③《长沙药解》:“微温,入足太阴脾、足阳明胃经。”④《纲目》:“甘,温,无毒。”1.《本草逢原》:“治产后胞衣不下,并用生者,又以煮熟去白取黄,用乱发香油熬化,涂婴儿胎毒热疮。”2.《中国动物药》:“滋阴润燥,养血息风,杀虫解毒。治心烦不眠,虚劳吐血,肝炎,消化不良,腹泻,漏疮等。”3.《药性论》:“和常山末为丸,竹叶煎汤下,洽久疟不差。治漆疮,涂之。醋煮,治产后虚及痢,主小儿发热。煎服,主痢,除烦热。炼之,主呕逆。”4.《千金·食治》:“主除热,火灼、烂疮,痓。”5.《本草求真》:“利产安胎。”6.《本草纲目》:“补阴血,解热毒,治下痢。”7.《本草再新》:“补中益气,养肾益阴,润肺止咳,能使心肾交,能教肺肾还。虚劳吐血,均有功焉。
鳆鱼:为鲍科动物九孔鲍或盘大鲍的肉。味甘;咸;性平。滋阴清热;益精明目。主劳热骨蒸;咳嗽;青盲内障;月经不调;带下;肾虚小便频数;大便燥结。
白芍:味苦、酸,性微寒,入肝、脾经,有养血合营,柔肝止痛,平抑肝阳的作用,主要用于肝阴不足、肝阳上亢之头痛脑胀、眩晕耳鸣、烦躁易怒;肝血不足,营卫空虚之月经不调,崩中漏下;肝虚血滞湿阻之痛经;营卫不和,营阴外越之自汗盗汗;肝气郁结之脘腹胁肋疼痛,泻痢腹痛;肝阴亏虚,经脉失养之手足痉挛疼痛等证。
鹿角胶:性味: 甘咸,温。归经: 入肝、肾经。功能主治: 补血,益精。治肾气不足,虚劳羸瘦,腰痛,阴疽,男子阳痿、滑精,妇女子宫虚冷,崩漏,带下。①《本经》:“主伤中劳绝;腰痛羸瘦,补中益气,妇人血闭无子,止痛安胎。”②《别录》:“疗吐血,下血,崩中不止,四肢酸疼,多汗,淋露,折跌伤损。”③《药性论》:“主男子肾藏气衰虚劳捐,能安胎去冷,治漏下赤白,主吐血。”④《医学入门》:“主咳嗽,吐血,咯血,嗽血,尿血,下血。”⑤《纲目》:“治劳嗽,尿精,尿血,疮疡肿毒。”⑥《玉楸药解》:“温肝补肾,滋益精血。治阳痿精滑,跌打损伤。”⑦《吉林中草药》:“补脑,强心。治大脑水肿。”
棉花子:辛;性热;有毒。归肾;脾;女子胞经。温肾;通乳;活血止血。主阳痿;腰膝冷痛;白带;贵尿;胃痛;乳汁不通;崩漏;痔血。
头发七:地衣类松萝科发属植物亚洲树发,以叶状体入药。淡,平。滋补肝肾,收敛止汗。用于头晕,洗净,肾虚体弱,遗精,盗汗;外用治黄水疮。
蛇床子:本品为伞形科植物蛇床的干燥成熟果实。辛、苦,温;有小毒。归肾经。温肾壮阳,燥湿,祛风,杀虫。用于阳痿,宫冷,寒湿带下,湿痹腰痛;外治外阴湿疹,妇人阴痒;滴虫性阴道炎。
南烛子:杜鹃花科乌饭树属植物乌饭树,以干燥果实入药。微甘、酸。 强筋骨,益肾气。用于身体虚弱,脾虚久泄,梦遗滑精,赤白带下。
燕窝:甘,平。归肺、胃、肾经。养阴润燥,益气补中。治虚损,痨瘵,咳嗽痰喘,咯血,吐血,久痢,久疟,噎膈反胃。养肺阴,化痰,止咳。主治肺虚痨嗽,咳喘,痿损潮热等症。
枸杞:枸杞子:甘,平。入肝、肾、肺经。治肝肾阴亏,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,阳痿遗精,内热消渴,血虚萎黄,目昏不明。《食疗本草》:“坚筋耐老,除风,补益筋骨,能益人,去虚劳。”枸杞多糖具有促进免疫、抗衰老、抗肿瘤、清除自由基、抗疲劳、抗辐射、保肝、生殖功能保护和改善等作用。
豨莶:苦,寒。归肝、脾、肾经。祛风湿,利筋骨,降血压。治四肢麻痹,筋骨疼痛,腰膝无力,疟疾,急性肝炎,高血压病,疔疮肿毒,外伤出血。
覆盆子:甘、酸,温。归肾、膀胱经。益肾,固精,缩尿。用于肾虚遗尿,小便频数,阳痿早泄,遗精滑精。
原蚕蛾:为蚕蛾科昆虫家蚕蛾的雄性全虫。咸,温。归肝、肾经。补肝益肾,壮阳涩精。治阳痿,遗精,白浊,尿血,创伤,溃疡及烫伤。
枸骨根:为冬青科植物枸骨Ilex cornuta.ex Paxt.的根。苦;凉。补肝益肾;疏风清热。主腰膝痿弱;关节疼痛;头风;赤眼;牙痛;荨麻疹。
骨碎补:苦,温。归肾、肝经。补肾强骨,续伤止痛。用于肾虚腰痛,耳鸣耳聋,牙齿松动,跌扑闪挫,筋骨折伤;外治斑秃,白癜风。
菟丝子:气味辛,甘,平,无毒。归肝肾经。补肾益精,养肝明目。适用于肝肾不足的腰膝筋骨酸痛,腿脚软弱无力、阳痿遗精、呓语、小便频数、尿有余沥、头晕眼花、视物不清、耳鸣耳聋以及妇女带下、习惯性流产等症。《别录》:“养肌强阴,坚筋骨,主茎中寒,精自出,溺有余沥,口苦燥渴,寒血为积。”《日华子本草》:“补五劳七伤,治泄精,尿血,润心肺。”补肾益精,养肝明目。适用于肝肾不足的腰膝筋骨酸痛,腿脚软弱无力、阳痿遗精、呓语、小便频数、尿有余沥、头晕眼花、视物不清、耳鸣耳聋以及妇女带下、习惯性流产等症。
千年健:苦,辛,温。归肝、肾经。祛风湿,健筋骨,活血止痛。用于风寒湿痹,腰膝冷痛,下肢拘挛麻木。
洋虫:为拟步虫科昆虫洋虫的全虫。味辛;甘;性温。肺;胃;大肠经。温中理气;活血止痛;祛风除湿。主心胃气痛;腹胀吐泻;跌情报检索损伤;半身不遂;肢体痿痹;劳伤咳嗽;月经下调;赤白带下。
山茱萸:酸、涩、微温;入肝、心、肾三经。补肝肾,涩精气,固虚脱。治腰膝酸痛,眩晕,耳鸣,阳痿,遗精,小便频数,肝虚寒热,虚汗不止,心摇脉散。《名医别录》载:“山茱萸微温,无毒。主治肠胃风邪,寒热疝瘕,……耳聋,下气,出汗,益精,安五脏,通九窍,止小便利。”《汤液本草》:“滑则气脱,涩剂所以收之,山茱萸止小便利,秘精气取其味酸涩以收滑也。”补肝肾,涩精气,固虚脱。治腰膝酸痛,眩晕,耳鸣,阳痿,遗精,小便频数,肝虚寒热,虚汗不止,心摇脉散。
山药:味甘,性平,入肺、脾、肾经,具有健脾补肺、益胃补肾、固肾益精、聪耳明目、助五脏、强筋骨、长志安神、延年益寿的功效,主治脾胃虚弱、倦怠无力、食欲不振、久泄久痢、肺气虚燥、痰喘咳嗽、肾气亏耗、腰膝酸软、下肢痿弱、消渴尿频、遗精早泄、带下白浊、皮肤赤肿、肥胖等证。
陈皮:性味苦、辛,温。归肺、脾经。具有理气健脾,燥湿化痰的功用。可用于胸脘胀满,食少吐泻,咳嗽痰多。故陈皮有三大类作用,一是导胸中寒邪,二破滞气,三益脾胃。这三大作用中,主要作用是行脾胃之气。脾胃主运化水湿,故脾胃之气行则能去湿、健脾、化痰,故又可以说,陈皮温能养脾,辛能醒脾,苦能健脾。由于陈皮主行脾胃之气,脾胃地处中焦,中焦之气通行,使三焦之气也随之涌动。
干姜:辛、热。归脾、胃、肾、心、肺经。干姜温中散寒,回阳通脉,燥湿消痰。用于脘腹冷痛,呕吐泄泻,肢冷脉微,痰饮喘咳。
地龙:咸,寒。归肝、脾、膀胱经。清热定惊,通络,平喘,利尿。用于高热神昏,惊痫抽搐,关节痹痛,肢体麻木,半身不遂,肺热喘咳,尿少水肿,高血压。
秦艽:辛、苦,平。归胃、肝、胆经。祛风湿,清湿热,止痹痛。用于风湿痹痛,筋脉拘挛,骨节酸痛,日晡潮热,小儿疳积发热。
桑枝:微苦,平。归肝经。祛风湿,利关节。用于肩臂、关节酸痛麻木。
煅龙骨:将刷净的龙骨,放坩锅内或其它容器中煅至红透,取出晾凉,碾碎即可。甘、涩,平。镇静,敛汗涩精,生肌敛疮。用于神经衰弱,心悸,失眠,多梦,自汗,盗汗,遗精,遗尿,崩漏,带下;外用治疮疡久溃不敛。
煅牡蛎:取净牡蛎,照明煅法煅至酥脆。咸,微寒。归肝、胆、肾经。重镇安神,潜阳补阴,软坚散结。用于惊悸失眠,眩晕耳鸣,瘰疬痰核,症瘕痞块。煅牡蛎收敛固涩。用于自汗盗汗,遗精崩带,胃痛吞酸。
煅石膏:取净石膏,在无烟炉火中或坩锅内煅至酥松,取出晾凉,打碎即可。甘、辛,大寒。归肺、胃经。清热泻火,除烦止渴。用于外感热病,高热烦渴,肺热喘咳,胃火亢盛,头痛,牙痛。
葛根:甘、辛,凉。归脾、胃经。解肌退热,生津,透疹,升阳止泻。用于外感发热头痛、项背强痛,口渴,消渴,麻疹不透,热痢,泄泻;高血压颈项强痛。
神曲:为辣蓼、青蒿、杏仁等药加入面粉或麸皮混和后,经发酵而成的曲剂。甘辛,温。归脾、胃经。健脾和胃,消食调中。治饮食停滞,胸痞腹胀,呕吐泻痢,产后瘀血腹痛,小儿腹大坚积。
莱菔子:辛、甘,平。归肺、脾、胃经。消食除胀,降气化痰。用于饮食停滞,脘腹胀痛,大便秘结,积滞泻痢,痰壅喘咳。
以下采用实施例来详细说明本发明的实施方式,借此对本发明如何应用技术手段来解决技术问题,并达成技术效果的实现过程能充分理解并据以实施。
实施例1 本发明的蜜炼丸剂
本发明实施例提供了一种治疗骨质疏松的药物,由以下重量的原料药材制得:熟地26g、龟板胶22g、鸡子黄11g、鳆鱼12g、白芍32g、鹿角胶33g、棉花子5g、头发七12g、蛇床子7g、南烛子13g、燕窝31g、枸杞25g、豨莶10g、覆盆子29g、原蚕蛾17g、枸骨根8g、骨碎补26g、菟丝子13g、千年健22g、洋虫14g、山茱萸30g、山药15g、陈皮29g、干姜14g、地龙16g、秦艽11g、桑枝7g、煅龙骨10g、煅牡蛎7g、煅石膏10g、葛根10g、神曲18g和莱菔子12g。
其制备方法包括以下步骤:
步骤1:先将煅龙骨、煅牡蛎、煅石膏按所述比例混合粉碎过200目-300目筛得粉末;
步骤2:再取剩余原料药材按所述比例混合,加相对于混合物3倍量的90%乙醇浸泡1小时、加热提取2次,每次1小时,合并提取液、150目滤过,再经截流分子量为98000的超滤柱超滤,超滤液减压浓缩至87℃时相对密度为1.04的浸膏,成为组分1;
步骤3:将步骤2中药渣加5倍量水浸泡1小时,加热煎煮2小时,过滤,浓缩滤液为浸膏状,为组分2;
步骤4:将上述组分1和组分2两种浸膏浓缩成糊状,加上步骤1得到的粉末,加蜂蜜搓成丸剂。
实施例2 本发明的颗粒剂
本发明实施例提供了一种治疗骨质疏松的药物,由以下重量的原料药材制得:熟地22g、龟板胶24g、鸡子黄17g、鳆鱼8g、白芍30g、鹿角胶30g、棉花子8g、头发七10g、蛇床子10g、南烛子11g、燕窝28g、枸杞33g、豨莶12g、覆盆子24g、原蚕蛾18g、枸骨根9g、骨碎补28g、菟丝子16g、千年健20g、洋虫12g、山茱萸34g、山药12g、陈皮32g、干姜12g、地龙11g、秦艽7g、桑枝11g、煅龙骨12g、煅牡蛎11g、煅石膏7g、葛根12g、神曲16g和莱菔子11g。
其制备方法包括以下步骤:
步骤一:先将煅龙骨、煅牡蛎、煅石膏按所述比例混合粉碎过200目筛得粉末;
步骤二:将剩余所述原料药材按所述比例混合,加相对于混合物4倍的醇浓度为95%的乙醇,加热至沸腾回流3小时,过滤,采用渗漉法以每分钟2ml的速度缓缓渗漉,收集渗漉液,随后在真空度0.09Mpa下减压浓缩至60℃时相对密度为1.10的膏体,喷雾干燥,喷雾干燥机的进风温度175℃、出风温度85℃,随后粉碎成粉末,制成干膏粉;
步骤三:将步骤一获得的粉末和步骤二获得的干膏粉混合均匀,然后加入相对于混合物质量0.4倍的蔗糖粉和0.2倍的糊精,制成颗粒,于50℃干燥,获得颗粒剂。
实施例3 本发明的胶囊剂
本发明实施例提供了一种治疗骨质疏松的药物,由以下重量的原料药材制得:熟地28g、龟板胶18g、鸡子黄14g、鳆鱼14g、白芍26g、鹿角胶35g、棉花子9g、头发七13g、蛇床子9g、南烛子7g、燕窝33g、枸杞27g、豨莶14g、覆盆子26g、原蚕蛾15g、枸骨根6g、骨碎补22g、菟丝子19g、千年健17g、洋虫16g、山茱萸26g、山药14g、陈皮25g、干姜8g、地龙13g、秦艽12g、桑枝9g、煅龙骨8g、煅牡蛎9g、煅石膏6g、葛根15g、神曲12g和莱菔子15g。
其制备方法包括以下步骤:
第一步,先将煅龙骨、煅牡蛎、煅石膏按所述比例混合,粉碎过300目筛得粉末;
第二步,将熟地、龟板胶、鸡子黄、鳆鱼和白芍按所述比例混合,加相对于混合物5倍的水提取挥发油,将获得的挥发油用β-环糊精包合,挥发油与β-环糊精的质量比例为1∶4,搅拌90分钟,温度50℃,得挥发油包合物,备用;另将水提取液浓缩至60℃时相对密度为1.17的清膏;
第三步,将鹿角胶、棉花子、头发七、蛇床子和南烛子按所述比例混合,加相对于混合物6倍量醇浓度为90%的乙醇回流提取4次,每次2小时,分别过滤,各次滤液合并,回收乙醇,浓缩至60℃时相对密度为1.20的清膏,备用;
第四步,将剩余所述原料药材按所述比例混合,加相对于混合物9倍量水,煮沸7小时,过滤,浓缩至60℃时相对密度为1.30的清膏;
第五步,将第二步、第三步、第四步的清膏混合,70℃减压真空干燥,得干膏粉;
第六步,将第一步所得粉末、第二步所述挥发油包合物和第五步所述干膏粉充分混合得混合物,随后加入相对于100重量份所述的混合物,7重量份羧甲基淀粉钠、40重量份淀粉混合均匀,加入200重量份醇浓度为90%乙醇制粒,干燥,整粒,随后加入相对于100重量份所述挥发油包合物和干膏粉的混合物,4重量份硬脂酸镁,然后装入明胶胶囊中。
毒性实验:
急性毒性试验:应用NIH小鼠40只,SPF级,雌雄各半,体重18~22g,进行急性毒性试验。小鼠随机分为两组,每组20只,即对照组和给药组,实验前禁食12小时;将本发明的实施例1制备的蜜炼丸剂溶解在水中,(浓度为6.58g生药/ml,最高浓度)灌胃,灌胃容积为5ml/kg(即单次给药剂量为32.9生药/kg),对照组给予等量生理盐水,一天给药2次,给药间隔时间6小时,给药后连续观察14天,并记录小鼠的的毒性反应及死亡数。实验结果表明:与对照组比较,给药后小鼠未见明显差异,实验连续观察14天,小鼠全身状况、饮食、饮水、体重增长均正常。小鼠口服灌胃本发明的蜜炼丸剂LD50>32.9生药/kg,每日最大给药量为65.8生药/kg/日。本发明的药物临床用药量为4.4g生药/日/人,成人体重以60KG计,平均用药剂量为0.073g生药/kg/日。按体重计:小鼠(平均体重以20g计)口服灌胃本发明的药物的耐受量为临床用量的901倍。因此本发明实施例1的蜜炼丸剂急性毒性低,临床用药安全。
长期毒性实验:将本发明实施例2的颗粒剂对小鼠按6.43、15.72和36.41g生药/kg连续用药16周(1.0ml/100g体重,每天2次)及停药4周后,结果表明:本发明中药制剂对小鼠的毛发、行为、大小便、体重、脏器重量、血象、肝肾功能、血糖、血脂等指标均无明显影响,脏器肉眼没有发现异样变化和组织学检查结果表明,用药16周及停药4周后,小鼠各脏器均无明显改变。说明本发明中药制剂对小鼠长期用药后毒性小,停药后也没有异样反应,应用安全。
长期毒性实验:将本发明实施例3的胶囊剂对小鼠按6.43、15.72和36.41g生药/kg连续用药16周(1.0ml/100g体重,每天2次)及停药4周后,结果表明:本发明中药制剂对小鼠的毛发、行为、大小便、体重、脏器重量、血象、肝肾功能、血糖、血脂等指标均无明显影响,脏器肉眼没有发现异样变化和组织学检查结果表明,用药16周及停药4周后,小鼠各脏器均无明显改变。说明本发明中药制剂对小鼠长期用药后毒性小,停药后也没有异样反应,应用安全。
临床资料
西医的骨质疏松诊断标准参照《中国人原发性骨质疏松症诊断标准(试行)》,根据国际诊断标准,同时结合中国人的特点,按照骨密度低于同种族、同性别、同部位健康人骨峰值骨量平均值减去两个标准差(- 2.0SD),即可诊断为骨质疏松症。
230例原发性骨质疏松患者中,男130例,女100例, 年龄52-73岁,平均年龄55岁,平均病程7.1年,所有患者均未患影响骨代谢的风湿、内分泌、免疫等疾病。将230位患者随机分为4组,四组差异无统计学意义(P>0.05),具有可比性。
蜜炼丸剂治疗组:58人,男33人,女25人;口服本发明实施例1制备的蜜炼丸剂,一日3次,一次4粒,1个月为一疗程;
颗粒剂治疗组:57人,男32人,女25人;使用本发明实施例2制备的颗粒剂,一日3次,一次1包,1个月为一疗程;
胶囊剂治疗组:58人,男33人,女25人;使用本发明实施例3制备的胶囊剂,一日3次,一次3颗,1个月为一疗程;
对照组:57人,男32人,女25人;口服阿法骨化醇软胶囊0.5μg(2粒),一日1次;口服葡萄糖酸钙口服溶液一次1支,一日3次;口服氯甲双磷酸二钠,1.6 g/日,分两次服用,在进饮食前和后2小时,餐间服用,1个月为一疗程。
采用双能X 线骨密度测定仪( DEXA),测定左前臂远端1/3 桡骨总体骨密度( g/cm2 )。
骨质疏松疗效评定标准:
临床主要症状的观察参照中国人骨质疏松症建议诊断标准。
显效: 腰背疼痛基本消失,功能活动正常。
有效: 腰背疼痛减轻,功能活动基本正常。
无效: 腰背疼痛未减轻,功能活动未改善
治疗结果:
参见表1,从表1可以看出,采用本发明的中药治疗骨质疏松,相对于对照组在治疗效果上,具有显著的改进。
表1 四组分别治疗2个月后临床疗效比较 例(%)
组别 | 例数 | 显效 | 有效 | 无效 | 总有效率 |
蜜炼丸剂治疗组 | 58 | 44 | 13 | 1 | 98.3% |
颗粒剂治疗组 | 57 | 42 | 12 | 3 | 94.7% |
胶囊剂治疗组 | 58 | 43 | 13 | 2 | 96.6% |
对照组 | 57 | 26 | 11 | 20 | 64.9% |
表2四组分别治疗2个月后治疗前后BMD值得变化(g/cm2)
组别 | 例数 | 治疗前 | 治疗后 |
蜜炼丸剂治疗组 | 58 | 0.5015±0.069 | 0.5573±0.060 |
颗粒剂治疗组 | 57 | 0.4986±0.075 | 0.5489±0.062 |
胶囊剂治疗组 | 58 | 0.4966±0.064 | 0.5517±0.059 |
对照组 | 57 | 0.5076±0.073 | 0.5297±0.067 |
从表2以看出,采用本发明的药物治疗骨质疏松,相对于对照组在治疗效果上,具有显著的改进。采用本发明的药物治疗骨质疏松治疗后BMD 值明显提高,改善程度明显优于对照组。
典型病例:2012年6月,患者汤某,男,70岁,因腰痛就诊,健忘,舌瘦,脉细无力,伴有脱发齿松,耳鸣耳聋,腰膝酸软,经体检和肾功能检查未见异常,X线检查显示:管状骨皮质变薄,髓腔变宽,骨小梁数目减少,其间隙也增宽,确诊为骨质疏松。服用本发明药物制剂实施例1的蜜炼丸剂,一日3次,一次4粒,治疗1个月后腰背疼痛减轻,功能活动基本正常,治疗2个月后腰背疼痛基本消失,功能活动正常。
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (8)
1.一种治疗骨质疏松的药物,其特征在于,以重量份计,所述药物的原料药组成为:熟地20-30份、龟板胶17-25份、鸡子黄10-18份、鳆鱼7-17份、白芍25-34份、鹿角胶28-36份、棉花子5-10份、头发七9-14份、蛇床子6-11份、南烛子6-15份、燕窝26-35份、枸杞23-38份、豨莶9-15份、覆盆子23-30份、原蚕蛾14-19份、枸骨根5-10份、骨碎补20-30份、菟丝子12-20份、千年健15-24份、洋虫10-18份、山茱萸25-36份、山药11-17份、陈皮23-34份、干姜7-15份、地龙10-17份、秦艽5-14份、桑枝6-12份、煅龙骨7-13份、煅牡蛎6-12份、煅石膏5-11份、葛根9-16份、神曲11-19份和莱菔子10-17份。
2.如权利要求1所述的药物,其特征在于,以重量份计,所述药物的原料药组成为:熟地22-28份、龟板胶18-24份、鸡子黄11-17份、鳆鱼8-14份、白芍26-32份、鹿角胶30-35份、棉花子5-9份、头发七10-13份、蛇床子7-10份、南烛子7-13份、燕窝28-33份、枸杞25-33份、豨莶10-14份、覆盆子24-29份、原蚕蛾15-18份、枸骨根6-9份、骨碎补22-28份、菟丝子13-19份、千年健17-22份、洋虫12-16份、山茱萸26-34份、山药12-15份、陈皮25-32份、干姜8-14份、地龙11-16份、秦艽7-12份、桑枝7-11份、煅龙骨8-12份、煅牡蛎7-11份、煅石膏6-10份、葛根10-15份、神曲12-18份和莱菔子11-15份。
3.如权利要求1或2所述的药物,其特征在于,以重量份计,所述药物的原料药组成为:熟地26份、龟板胶22份、鸡子黄11份、鳆鱼12份、白芍32份、鹿角胶33份、棉花子5份、头发七12份、蛇床子7份、南烛子13份、燕窝31份、枸杞25份、豨莶10份、覆盆子29份、原蚕蛾17份、枸骨根8份、骨碎补26份、菟丝子13份、千年健22份、洋虫14份、山茱萸30份、山药15份、陈皮29份、干姜14份、地龙16份、秦艽11份、桑枝7份、煅龙骨10份、煅牡蛎7份、煅石膏10份、葛根10份、神曲18份和莱菔子12份。
4.如权利要求1或2所述的药物,其特征在于,以重量份计,所述药物的原料药组成为:熟地22份、龟板胶24份、鸡子黄17份、鳆鱼8份、白芍30份、鹿角胶30份、棉花子8份、头发七10份、蛇床子10份、南烛子11份、燕窝28份、枸杞33份、豨莶12份、覆盆子24份、原蚕蛾18份、枸骨根9份、骨碎补28份、菟丝子16份、千年健20份、洋虫12份、山茱萸34份、山药12份、陈皮32份、干姜12份、地龙11份、秦艽7份、桑枝11份、煅龙骨12份、煅牡蛎11份、煅石膏7份、葛根12份、神曲16份和莱菔子11份。
5.如权利要求1或2所述的药物,其特征在于,以重量份计,所述药物的原料药组成为:熟地28份、龟板胶18份、鸡子黄14份、鳆鱼14份、白芍26份、鹿角胶35份、棉花子9份、头发七13份、蛇床子9份、南烛子7份、燕窝33份、枸杞27份、豨莶14份、覆盆子26份、原蚕蛾15份、枸骨根6份、骨碎补22份、菟丝子19份、千年健17份、洋虫16份、山茱萸26份、山药14份、陈皮25份、干姜8份、地龙13份、秦艽12份、桑枝9份、煅龙骨8份、煅牡蛎9份、煅石膏6份、葛根15份、神曲12份和莱菔子15份。
6.如权利要求1或2所述的药物,其特征在于,所述药物的剂型为蜜炼丸剂时,其制备方法包括以下步骤:
步骤1:先将煅龙骨、煅牡蛎、煅石膏按所述比例混合粉碎过200目-300目筛得粉末;
步骤2:再取剩余原料药材按所述比例混合,加相对于混合物2-6倍量的83-94%乙醇浸泡1-2小时、加热提取2次,每次1-1.5小时,合并提取液、124-150目滤过,再经截流分子量为4400-98000的超滤柱超滤,超滤液减压浓缩至87℃时相对密度为1.04的浸膏,成为组分1;
步骤3:将步骤2中药渣加4-6倍量水浸泡1-2.5小时,加热煎煮1.5-2小时,过滤,浓缩滤液为浸膏状,为组分2;
步骤4:将上述组分1和组分2两种浸膏浓缩成糊状,加上步骤1得到的粉末,加蜂蜜搓成丸剂。
7.如权利要求1或2所述的药物,其特征在于,所述药物的剂型为颗粒剂时,其制备方法包括以下步骤:
步骤一:先将煅龙骨、煅牡蛎、煅石膏按所述比例混合粉碎过200目-300目筛得粉末;
步骤二、将剩余所述原料药材按所述比例混合,加相对于混合物4~8倍的醇浓度为85%~95%的乙醇,加热至沸腾回流3~5小时,过滤,采用渗漉法以每分钟1~2ml的速度缓缓渗漉,收集渗漉液,随后在真空度0.06~0.09Mpa下减压浓缩至50~60℃时相对密度为1.04~1.10的膏体,喷雾干燥,喷雾干燥机的进风温度160~175℃、出风温度80~85℃,随后粉碎成粉末,制成干膏粉;
步骤三:将步骤一获得的粉末和步骤二获得的干膏粉混合均匀,然后加入相对于混合物质量0.2~0.4倍的蔗糖粉和0.1~0.2倍的糊精,制成颗粒,于40~50℃干燥,获得颗粒剂。
8.如权利要求1或2所述的药物,其特征在于,所述药物的剂型为胶囊剂时,其制备方法包括以下步骤:
第一步,先将煅龙骨、煅牡蛎、煅石膏按所述比例混合,粉碎过200目-300目筛得粉末;
第二步,将熟地、龟板胶、鸡子黄、鳆鱼和白芍按所述比例混合,加相对于混合物4~6倍的水提取挥发油,将获得的挥发油用β-环糊精包合,挥发油与β-环糊精的质量比例为1∶3~6,搅拌60分钟~90分钟,温度30℃~50℃,得挥发油包合物,备用;另将水提取液浓缩至60℃时相对密度为1.15~1.17的清膏;
第三步,将鹿角胶、棉花子、头发七、蛇床子和南烛子按所述比例混合,加相对于混合物5~8倍量醇浓度为75%~90%的乙醇回流提取3~5次,每次2~3小时,分别过滤,各次滤液合并,回收乙醇,浓缩至60℃时相对密度为1.20~1.22的清膏,备用;
第四步,将剩余所述原料药材按所述比例混合,加相对于混合物8~10倍量水,煮沸6~8小时,过滤,浓缩至60℃时相对密度为1.28~1.30的清膏;
第五步,将第二步、第三步、第四步的清膏混合,60℃~70℃减压真空干燥,得干膏粉;
第六步,将第一步所得粉末、第二步所述挥发油包合物和第五步所述干膏粉充分混合得混合物,随后加入相对于100重量份所述的混合物,5~7重量份羧甲基淀粉钠、5~50重量份淀粉混合均匀,加入150~200重量份醇浓度为80%~90%乙醇制粒,干燥,整粒,随后加入相对于100重量份所述挥发油包合物和干膏粉的混合物,3~5重量份硬脂酸镁,然后装入明胶胶囊中。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510000459.6A CN104524524B (zh) | 2015-01-04 | 2015-01-04 | 一种治疗骨质疏松的药物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510000459.6A CN104524524B (zh) | 2015-01-04 | 2015-01-04 | 一种治疗骨质疏松的药物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104524524A CN104524524A (zh) | 2015-04-22 |
CN104524524B true CN104524524B (zh) | 2015-07-08 |
Family
ID=52840280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510000459.6A Expired - Fee Related CN104524524B (zh) | 2015-01-04 | 2015-01-04 | 一种治疗骨质疏松的药物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104524524B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105079400A (zh) * | 2015-08-31 | 2015-11-25 | 南京正宽医药科技有限公司 | 一种治疗骨质疏松的药物制剂 |
CN106421274A (zh) * | 2016-11-30 | 2017-02-22 | 广西慧投互联网金融服务有限公司 | 一种治疗骨质疏松的混合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103479962B (zh) * | 2013-05-22 | 2015-02-11 | 王解清 | 治疗人体颈椎、腰椎突出及增生的中药制剂 |
CN105412587A (zh) * | 2014-02-11 | 2016-03-23 | 青岛华之草医药科技有限公司 | 一种制备治疗女性绝经后骨质疏松症的药物组合物的方法 |
-
2015
- 2015-01-04 CN CN201510000459.6A patent/CN104524524B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104524524A (zh) | 2015-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100423761C (zh) | 一种治疗骨折、跌打损伤的中药制剂 | |
CN1628760A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN102755593B (zh) | 一种治疗气瘿的中药组合物及其制备方法 | |
CN103735791B (zh) | 一种治疗腰椎、骨质疾病的中药组合物及其制备方法 | |
CN102526597B (zh) | 一种治疗口臭的药物及其制备方法 | |
CN107432881A (zh) | 一种中药组合物、制备方法及其在改善和治疗男性性功能方面的应用 | |
CN104524524B (zh) | 一种治疗骨质疏松的药物及制备方法 | |
CN103263601A (zh) | 一种加速骨折手术后愈合速度的中药制剂及制备方法 | |
CN105031013A (zh) | 一种治疗腰椎骨质增生的药物及其制备方法 | |
CN104069463B (zh) | 一种治疗妇科崩漏的中药药剂 | |
CN103432274B (zh) | 一种治疗偏头痛的药物及其制备方法 | |
CN102671180B (zh) | 一种治疗风湿腰痛的药物及其制备方法 | |
CN103751301B (zh) | 用于股骨头无菌性坏死患者的制品 | |
CN105521473A (zh) | 一种治疗小儿麻痹后遗症的药物及其制备方法 | |
CN104888133A (zh) | 一种治疗冠心病的中药组合物 | |
CN103989968A (zh) | 一种口服治疗颈椎管狭窄症中药组合物 | |
CN103933473B (zh) | 一种补气养血祛斑美容的颗粒剂及其制备方法 | |
CN102028837B (zh) | 一种疗骨胶囊的组配方法 | |
CN105169089A (zh) | 一种用于治疗经行头痛的中药丸剂及制备方法 | |
CN106177857A (zh) | 一种治疗习惯性流产的药物及其制备方法 | |
CN106266427A (zh) | 一种治疗肾病的中药药酒及其制备方法 | |
CN104758849A (zh) | 一种治疗绝经期骨质疏松症的药物组合物及其制备方法 | |
CN105381409A (zh) | 一种治疗胆石症的药物及其制备方法 | |
CN105288396A (zh) | 一种治疗气滞血瘀型原发性骨质疏松症的中药及制备方法 | |
CN105267654A (zh) | 用于医治骨质疏松的制剂及制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150708 Termination date: 20180104 |